Get started
Elmind

CTXR in Accumulation phase of Uptrend Buying at $1.49 and holdin

Long
Citius Pharmaceuticals, Inc. (NASDAQ:CTXR)  
Elmind  
NASDAQ:CTXR   Citius Pharmaceuticals, Inc.
Trend Analysis
8
8
trendanalysis
Great opportunity here. CTXR in currently in early stage of accumulation phase of uptrend. Great time to get in before it gets to Absorption or distribution phases. We will Buy at $1.49, hold and take profits at various stops on the way up.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.